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r the Study of the Liver. PublishedSummary Background: Adequate bowel preparation is an important quality indicator of co-
lonoscopy. This study validated whether the bowel cleansing quality and adenoma detection
rate (ADR) could be different between two bowel preparation schedules in individuals
receiving health examinations.
Methods: We enrolled individuals who had received a colonoscopy as part of the regimen for
their health checkup program with split-dose phosphosoda for bowel preparation. Prior to
December 31, 2012, the second dose of phosphosoda was administered at 10:00 PM before
the day of the colonoscopy and the individuals were defined as the 10-PM group. After January
1, 2013, the schedule was changed to 4:00 AM the same day as the colonoscopy and was
defined as the 4-AM group. The bowel cleansing quality was assessed using the Aronchick
scale.
Results: A total of 431 individuals were included, 259 in the 10-PM group and 172 in the 4-AM
group. The 4-AM group individuals had a higher rate of excellent or good bowel cleansing qual-
ity as compared with the 10-PM group (77.3% vs. 22%, respectively; p < 0.001). The ADR was
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Screening and surveillance colonoscopy can reduce the
disease burden and also decreases the mortality rate of
colorectal cancer [1e4]. However, up to 9% of colorectal
cancers are interval cancers and > 70% of interval cancers
are attributed to missed lesions [5]. Thus, examining how to
better achieve a high quality colonoscopy should be
considered very important [6,7].
Proper bowel preparation is important in order to pro-
vide a high quality colonoscopy and improve the adenoma
detection rate (ADR). A split-dose regimen is commonly
applied for the preprocedure bowel preparation [8,9].
Recent studies emphasize that the time of the second dose
of administration of cleansing agent being within < 6 hours
prior to colonoscopy may improve the bowel preparation
quality, especially for the right-side colon [10e12].
Because colorectal cancer screening accounts for 50% of
incidence and 53% of mortality reduction, screening colo-
noscopy is now an important examination involved in the
health checkup programs for many in the general popula-
tion [4]. We thus validated whether the bowel cleansing
quality and ADR could be improved by modifying the time
schedules of bowel preparation in individuals receiving
screening or surveillance colonoscopy as part of their
health examination.
Participants and methods
We conducted this study at the health management center
of the National Cheng Kung University Hospital, Tainan,
Taiwan. The participants were enrolled between July 2012
and June 2013. During July 2012 to December 2012, the
enrolled individuals received 45 mL of sodium phosphate
twice (Fleet; C.B. Fleet Company Inc., Lynchburg, VA, USA)
as part of their bowel preparation program at noon and at
10:00 PM on the day before their colonoscopy (10-PM group).
Between January 1, 2013 and June 30, 2013 the Fleet
timing schedule was changed, and the individuals received
Fleet at 6:00 PM in the evening on the day before their co-
lonoscopy and at 4:00 AM on the morning of the colonoscopy
(4-AM group). Accordingly, this was an interventional study
with a nonconcurrent control group (4-AM as intervention
group and 10-PM as control group). The primary endpoint
was the bowel cleansing quality and the secondary
endpoint was the ADR, as compared between both groups.
All the participants who received colonoscopy as part of
their health checkup program with split-dose sodium
phosphate for bowel preparation were enrolled. The pa-
tients were excluded from the analysis if any of the
following criteria were present: (1) the colonoscopy wasnot completed; (2) they did not follow the bowel prepara-
tion schedule; (3) they had a history of previous intestinal
surgery; (4) the patients did not receive further poly-
pectomy in our hospital to provide the histological result.
All the participants provided signed informed consents
and completed a patient report form, which recorded the
actual administration time of the second dose. The colo-
noscopies were scheduled between 9:00 AM and noon.
Before their examination, participants received detailed
information with regard to diet and the standard split-dose
bowel preparation regimen with Fleet (1 bottle taken
2 times).
All colonoscopies were performed by experienced
endoscopists. Most participants received premedication of
antispasmodic agents and were sedated with intravenous
propofol infusion if there were no contraindications. The
smaller colonic neoplasms were removed by biopsy forceps
or cold snare polypectomy during the examination. If the
neoplasms were too large, a second colonoscopy was
scheduled to remove those by cauterized polypectomy. All
removed specimens were then sent for histological
analysis.
The bowel cleansing quality was analyzed by a validated
Aronchick scale [13]. It provided a qualitative global
assessment based on the percentage of mucosal surface
seen and the amount of liquid/solid stool present: excellent
(> 95% of surface seen); good (> 90% of surface seen); fair
(some semisolid stool that could be suctioned or washed
away but > 90% of surface seen); and poor (< 90% of sur-
face seen).
The location of the colorectal lesion was recorded as an
anatomical location or as the distance from the anal verge.
A proximal lesion was defined as a lesion located above the
splenic flexure or > 40 cm above the anal verge. A distal
lesion was defined as a lesion located between the
descending colon and the rectum or < 40 cm above the anal
verge. The definition of advanced colorectal neoplasm was
polyp size > 1 cm, villous component, high-grade dysplasia,
or adenocarcinoma. Furthermore, the possible confounding
factors of bowel cleansing quality and colorectal neoplasm
were also recorded for statistical analysis, such as body
mass index (BMI), diabetes mellitus, dyslipidemia, smoking,
alcohol, colon polyp history, and so on.Statistical analysis
We used SPSS software version 15.0 (SPSS Inc., Chicago, IL,
USA) for statistical analysis. The Chi-square test and the
Student t test were used for measurement of the statistical
difference between the two study groups. A two-tailed
p < 0.05 was taken to be significant. In order to attain
Figure 1 The bowel cleansing quality assessed by the Aron-
chick scale was significantly better in the 4-AM group as
compared with the 10-PM group (p < 0.001, Chi-square test).
14 J.-W. Kang et al.statistical power at 0.8 with a two-sided test, a sample size
of at least 126 individuals in each group was estimated
based on achieving the primary endpoint of increasing the
bowel cleansing rate from 70% to 85%. The univariate cor-
relation and multivariate regression model were analyzed
to determine the independent factors related to bowel
cleansing quality and ADR.
Results
A total of 534 adults received colonoscopy with sodium
phosphate as their bowel preparation during the study
period. Seven participants with failure of cecal intubation
and another 27 patients that did not write the actual
administration time of the second dose of Fleet on their
patient report form were all excluded. Seven participants
who dropped out, by not returning for the polypectomy at
the National Cheng Kung University Hospital, were also
excluded. In addition, 43 participants (14.3%) in the 10-PM
group and 26 participants (13.2%) in the 4-AM group did not
comply with the advised bowel preparation schedule.
These participants were also excluded. Accordingly, a total
of 431 participants were finally enrolled for analysis,
including 259 in the 10-PM group and 172 in the 4-AM group.
The demographic data, including risk factors of colo-
rectal neoplasm, BMI, obesity, personal history of smoking,
alcohol, colon polyp, and family history of colon cancer,
were similar between the two study groups (Table 1). As
shown in Fig. 1, the individuals in the 4-AM group had a
significantly better bowel cleansing quality than those in
the 10-PM group. Accordingly, 77.3% of individuals in the
4-AM group had excellent or good bowel cleansing quality
compared to 22% in the 10-PM group (p < 0.001). Of the 431Table 1 The demographic backgrounds of the partici-






Age (y) 47.7  10.6 47.8  9.6 NS
Age  50 y [% (N )] 45.2 (117) 48.8 (84) NS
Sex (M/F) 153/106 102/70 NS
Obesity
[BMI > 27; % (N )]
14.7 (38) 13.4 (23) NS
Central obesity [% (N )] 37.1 (96) 40.1 (70) NS
Cholesterol (mg/dL) 200.7  43.3 204.2  37.8 NS
Triglyceride (mg/dL) 131.0  90.5 115.2  72.1 NS
High-density
lipoprotein (mg/dL)
53.6  15.8 56.2  17.4 NS
HbA1c (%) 5.5  0.7 5.6  0.7 NS
Smoking (N ) 70 47 NS
Alcohol (N ) 104 76 NS
Personal history of
colon polyp (N )
21 25 NS
Family history of
colon cancer (N )
27 25 NS
Data are presented as the mean  SD unless otherwise stated.
F Z female; HbA1c Z hemoglobin; M Z male; NS Z not sig-
nificant (by Chi-square test or Student t test); SD Z standard
deviation.enrolled participants, 128 were detected as having ade-
noma during the colonoscopy with an overall ADR of 29.7%.
The ADR in the 10-PM group was 25.5% (66/259) and it
significantly improved to 36% (62/172) in the 4-AM group
(p Z 0.019; Fig. 2). The mean number of adenoma in the
10-PM group was 0.45 and it increased significantly to 0.77 in
the 4-AM group (p Z 0.008). However, the advanced ADR
was not significantly different between the 10-PM and 4-AM
groups (4.6% vs. 4.1%, p Z NS).
Of the 128 participants with adenoma, 57 (44.5%) of the
patients’ adenomas were located in the proximal colon,
41 (32.0%) in the distal colon, and the other 30 (23.4%) had
both proximal and distal adenomas. The distribution of
adenoma is shown in Fig. 3dthe trend shows that more
proximal adenoma was found in the patients from the 4-AM
group as compared with the 10-PM group, but this did not
attain statistical significance. A total of 26 advanced
colonic neoplasms were found in 19 (4.4%) of the 128 par-
ticipants, which were 22 adenomas larger than 1 cm, fiveFigure 2 The adenoma detection rate (ADR) was significantly
higher in the 4-AM group as compared with the 10-PM group (36%
vs. 25.5%; p Z 0.019, Chi-square test).
Figure 3 The distribution of colonic adenoma between the
two study groups was not statistically significant.
Table 3 Multivariate analysis for the factors related to
bowel cleansing quality and ADR.
OR 95% CI p
Bowel cleansing quality
Sex (male vs. female) 0.54 0.32e0.92 0.023
Preparation schedule
(4-AM vs. 10-PM)
12.82 7.94e20.7 < 0.001





Age (per y) 1.04 1.01e1.06 0.002




Central obesity (yes vs. no) 1.55 0.99e2.43 0.055
Diabetes (yes vs. no) 1.83 0.83e4.03 0.13
Personal history of
adenoma (yes vs. no)
0.95 0.48e1.90 0.88
Family history of colon
cancer (yes vs. no)
2.64 1.40e4.99 0.003
ADR Z adenoma detection rate; CI Z confidence interval;
OR Z odds ratio.
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There were no villous adenomas or high-grade dysplastic
neoplasms. The advanced ADR was similar between the
10-PM and 4-AM groups (4.6% vs. 4.1%; p > 0.05). In addition,
large-sized adenomas and serrated adenomas were more
frequently detected in the proximal colon (Table 2).
Furthermore, univariate and multivariate analyses were
done for the possible confounding factors related to the
endpoint. In the univariate analysis, the sex, preparation
schedule, serum triglyceride, and serum lipoprotein were
associated with the bowel cleansing quality, and age, sex,
preparation schedule, obesity, diabetes, adenoma, and
colon cancer history were associated with the ADR. These
factors were further analyzed by multivariate analysis and
shown in Table 3. In the multivariate analysis the bowel
preparation schedule, age, sex, and family history of colon
cancer were all associated with the ADR, but only sex and
bowel preparation schedule were independent factors
related to bowel cleansing quality.
Discussion
Several items influence the quality of colonoscopy,
including bowel cleansing quality, cecal intubation rate,
adenoma detection rate, withdrawal time, the experience
of the colonoscopist, and rates of postprocedure bleeding
or perforation [6,7,10,12]. Adequate bowel preparation
seems to be one of the most important quality indicators
and is related to cecal intubation rate and ADRTable 2 The distribution and histopathology of the advanced c
Distribution Advanced adenoma, % (N ) Size  1 cm
TA SA/
Proximal 69.2 (18) 16 9 6
Distal 30.8 (8) 6 4 1
Total 100 (26) 22 13 7
SA/P Z serrated adenoma/polyp; TA Z tubular adenoma; TVA Z tub[6,7,12,14e19]. The acceptable level of proportion of
excellent or good bowel preparation is at least 90% [19]. A
split dose of cleansing agents is usually used to obtain
adequate bowel cleansing quality, but the time schedules
are different among various studies [20,21]. Some studies
emphasize that the timing of the second dose of cleansing
agent is important for the bowel cleansing effect [20,22].
Our present study further confirmed that by merely
changing the bowel preparation schedule from the 10-PM
group to the 4-AM group, which shortened the preparation
for colonoscopy interval, resulted in a dramatic improve-
ment of bowel cleansing quality (Fig. 1). Moreover, our
study showed that males had a higher adenoma detection
rate compared to females, even though the bowel cleansing
quality was relatively poor. These results are compatible
with previous studies [23,24]. In both univariate and
multivariate analyses, the bowel preparation schedule is an
independent factor of improved bowel cleansing quality.
The percentage of excellent or good bowel preparation
greatly increased from 22% in the 10-PM group to 77.3% in
the 4-AM group.
In addition to improving bowel cleansing quality, the
ADR also significantly increased from 25.5% to 36% when the
bowel preparation schedules were changed from 10-PM toolorectal neoplasms.
Histopathology data (N )
P TVA VA TA with moderate dysplasia Invasive cancer
3 0 1 0
2 0 0 1
5 0 1 1
ulovillous adenoma; VA Z villous adenoma.
16 J.-W. Kang et al.4-AM, as well as the mean number of adenomas per patient.
However, the advanced ADR was not increased, possibly
due to case number limitation or the young age of the study
population. Moreover, except for the preparation schedule,
the age, sex, and family history of colon cancer were also
independent factors related to ADR, which is similar to
other previous studies.
Our study had a much higher ADR of 29.7%, when
compared with another Taiwanese study that had 15.4%
[25]. The possible reasons to account for these findings
include that we enrolled both screening and surveillance
colonoscopy and did not exclude participants with bowel
habit changes, body weight loss, colon polyp history, or
family history of colorectal cancer in this study, which in
turn would lead to higher ADR.
Because interval cancer tends to locate at the proximal
colon, proximal adenoma detection becomes crucial to
alter the tumor biology by the protection effect of colo-
noscopy [2,26e30]. Studies in eastern and western coun-
tries revealed an increased prevalence of right-side
adenoma or cancer with increasing age [25,31e34]. Simi-
larly, this study showed a trend of increased proximal ad-
enoma in older participants. Moreover, advanced or
serrated adenomas were more frequently found in the
proximal colon. These results emphasize the importance of
bowel preparation quality as they relate to the protective
effect of screening colonoscopy.
In previous studies on split-dose bowel preparation, the
second dose of the cleansing agent was usually adminis-
trated between 5:00 AM and 7:00 AM [8,11]. Considering that
the duration of the Fleet effect was around 2 hours and
participants needed to arrive at the health management
center before 8:00 AM, the time of the second dose of Fleet
was set at 4:00 AM in our study. One may suggest that the 4-
AM schedule is too early to achieve adequate bowel prepa-
ration compliance. Nevertheless, > 85% of participants in
both groups could comply with the time schedule and there
were no statistically significant differences.
Although this study was a hospital-based study and the
sample size was relatively limited, our results demon-
strated the importance of the bowel preparation schedule
on bowel cleansing quality and were also linked to
improvement of the ADR. It indicated that by simply
changing the timing of the bowel preparation schedule we
could improve the adenoma detection efficacy. However,
our study has a number of limitations that should be noted.
First, our study population was relatively young with a
mean age < 50 years, but both advanced and proximal
neoplasms are more likely to be detected in the older
population. Thus, our result of no significant difference in
distribution of advanced neoplasm between the study
groups does not reflect the actual situation of the older
high-risk population. However, a study endpoint analysis
confined to the high-risk population could not be performed
because the case number of participants older than 50
years did not achieve a statistical level of power. Second,
the nonconcurrent control group (10-PM group) may have
some selection bias. However, the possible confounding
factors were not different between the study groups (Table
1); this may indicate that the influence of the bias was
small. Third, we excluded participants receiving poly-
ethylene glycol (Klean Prep), who may have been older.This may also underestimate adenoma prevalence. Fourth,
we did not prospectively record the other modifiable risk
factors for final analysis, such as diet pattern and physical
activity [35].
In summary, modifying the time schedule for bowel
preparation can improve the bowel cleansing quality and
increase the colonic ADR in a health management center.Conflicts of interest
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